Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening
Simone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Nadia Arang, Elena Sofia Cardenas-Alcoser, Kuniaki Sato, Gabriela Cuesta-Margolles, Justine S. Paradis, Monica Acosta, J. Silvio Gutkind · 2025
Read Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening by Simone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Nadia Arang, Elena Sofia Cardenas-Alcoser, Kuniaki Sato, Gabriela Cuesta-Margolles, Justine S. Paradis, Monica Acosta, J. Silvio Gutkind (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785119.txt.
Description
Simone Lubrano and co-authors go hunting for the escape routes eye melanoma cells use against targeted drugs. Uveal melanoma is driven by mutations that lock a growth pathway on. Local treatment controls the eye tumor, yet nearly half of patients still die of spread. Their 2025 screen forces one hundred pathway-activating genes, one at a time, into cancer cells bathed in targeted drugs.
Genes that let cells survive name the resistance machinery. Three escape families stood out: a JAK/STAT alarm pathway, anti-death proteins of the BCL family, and rewired growth circuits through PI3K/mTOR or Hippo signaling. Hits were rechecked in cells carrying the common BAP1 mutation. Oncologists get a map of the doors to block alongside the main drug.
Catalog record
| CREATOR | Simone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Nadia Arang, Elena Sofia Cardenas-Alcoser, Kuniaki Sato, Gabriela Cuesta-Margolles, Justine S. Paradis, Monica Acosta, J. Silvio Gutkind |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |